Il dilemma della prima linea del carcinoma polmonare non a piccole cellule in stadio avanzato: i farmaci di terza generazione sono tutti uguali?

Translated title of the contribution: The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?

Francesco Grossi, Filippo de Marinis, Luciano Frontini, Cesare Gridelli

Research output: Contribution to journalArticle

Translated title of the contributionThe dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?
Original languageItalian
Pages (from-to)5-14
Number of pages10
JournalTumori
Volume94
Issue number3
Publication statusPublished - May 2008

ASJC Scopus subject areas

  • Cancer Research

Cite this